A resident with anxiety, depressive disorder, and drug-induced dyskinesia, and with intact cognition per BIMS, was receiving multiple psychotropic medications, including an antidepressant, antianxiety, antipsychotic, and trazodone, without documented informed consent regarding risks and benefits. The care plan directed staff to educate the resident and family on psychotropic medication risks, benefits, and side effects, and assessments identified the medications as high risk with fall-related risk factors, yet the clinical record contained no consent documentation. Nursing staff reported being unaware of the psychotropic medication policy, and an administrative nurse stated that psychotropic evaluations and family notifications were usually done in-house, but in this case no psychotropic consent was obtained or documented because an outside provider managed the psychiatric medications.
A resident with dementia, anxiety, and depression had severely impaired cognition and was receiving multiple psychotropic medications, including an antipsychotic, an antianxiety medication, and an antidepressant. The EMR showed informed consent for some psychotropics, but not for trazodone. Staff stated consent was obtained for antipsychotics and that the facility should obtain consent for all psychotropic medications, but no policy for psychotropic consents was provided.
The facility failed to obtain complete and properly executed informed consents for psychotropic medications for multiple residents. Several residents were receiving antidepressants, antianxiety agents, and antipsychotics, yet their psychotropic consent forms were either missing signatures or did not list the specific medications, dosages, routes, or administration frequencies. Staff reported that informed consent was required before starting or changing psychotropic drugs and that consents were to be provided to residents or their representatives, and facility policy required signed consents at initiation and with dosage increases, but the documentation for these residents did not include the necessary medication details.
Facility staff failed to ensure informed consent and resident/representative education were documented for psychotropic meds for two residents. One resident had an increased olanzapine order without evidence of consent, and another had trazodone and citalopram orders without evidence of prior consent or education; staff interviews showed inconsistent understanding of when psychotropic consents were to be completed.
Failure to obtain updated psychotropic medication consent: A resident with depression, insomnia, anxiety, and chronic pain had intact cognition and was receiving antidepressant therapy and Lyrica for pain. The EHR showed a psychotropic consent for a lower Lyrica dose, but when the order was increased to TID, there was no evidence the resident or representative received education or informed consent for the dose/frequency change; an LN was unsure who completed consents, and an AN confirmed the consent was not accurate.
Failure to obtain informed consent for psychotropic meds: Five residents had active orders for antidepressants, antianxiety meds, a sleep med, and antipsychotics, but their EMR records lacked consent forms or other evidence that the resident or representative was informed of the risks and treatment details. Social Services stated there were no informed consents for psychotropic meds, and an RN stated notification was required before starting or changing these meds, with the nurse and Social Services handling the process.
Failure to Obtain Informed Consent for Psychotropic Medications: The facility failed to document informed consent for psychotropic meds for two residents. One resident had multiple antipsychotic, antidepressant, and antianxiety orders, but the consent forms lacked the resident’s signature. Another resident had orders for antianxiety, antipsychotic, antidepressant, and mood stabilizer meds, but the record contained no consent forms or evidence that the resident or representative was informed of the risks, benefits, and alternatives.
Failure to Obtain Informed Consent for Psychotropic Medications: A resident with dementia, psychotic disorder, and major depressive disorder was receiving an antidepressant and antipsychotic, but the record lacked evidence of informed consent for either medication. Staff stated the consent process had not been completed, despite the resident being alert, oriented, and able to understand and communicate.
Failure to document informed consent for a psychotropic medication. A resident with Alzheimer’s disease, anxiety, psychotic disorder, major depressive disorder, and severely impaired cognition was prescribed Buspar for anxiety, but the clinical record lacked evidence that the resident or representative was informed about the risks and benefits. Staff could not locate the consent or any note showing the medication was discussed.
Lack of Informed Consent for Psychotropic Medications: The facility failed to document informed consent for multiple residents receiving psychotropic medications, including antidepressants, antipsychotics, anxiolytics, and anticonvulsants used for psychotropic purposes. Record review showed no evidence that the resident and/or representative was informed of the potential adverse effects for several ongoing medication orders, and an RN stated consents were only completed when a new med was started.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.